Anticoagulation Clinical Trials

6 recruiting

Anticoagulation Trials at a Glance

17 actively recruiting trials for anticoagulation are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Beijing, Ann Arbor, and Asyut. Lead sponsors running anticoagulation studies include China National Center for Cardiovascular Diseases, Coherex Medical Inc., and Centre Hospitalier Universitaire Dijon.

Browse anticoagulation trials by phase

Treatments under study

About Anticoagulation Clinical Trials

Looking for clinical trials for Anticoagulation? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anticoagulation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anticoagulation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 3

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Acute Kidney Injury (AKI)Regional Citrate Anticoagulation (RCA)Continuous Renal Replacement Therapy (CRRT)
Vantive Health LLC40 enrolled14 locationsNCT05399537
Recruiting
Not Applicable

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

Atrial FibrillationStrokeOral Anticoagulation+1 more
Javelin Medical2,000 enrolled1 locationNCT05723926
Recruiting
Phase 2

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

Venous Thromboembolic DiseaseAutoimmune Hemolytic AnemiaProlonged Anticoagulation
Centre Hospitalier Universitaire Dijon72 enrolled1 locationNCT05089227
Recruiting
Phase 4

Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

AnticoagulationCoronary Endarterectomy
China National Center for Cardiovascular Diseases202 enrolled1 locationNCT05782270
Recruiting
Phase 3

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Bleeding Post Cardiac SurgeryIndication for Anticoagulation
Population Health Research Institute3,500 enrolled19 locationsNCT04284839
Recruiting
Not Applicable

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

BleedingPercutaneous Coronary InterventionCoronary Angiography+2 more
University Hospital, Strasbourg, France550 enrolled1 locationNCT06890312
Recruiting

Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions

Renal InjuryRegional Citrate Anticoagulation
Fujian Provincial Hospital30 enrolled1 locationNCT06021080
Recruiting
Phase 1

Phase I Study of MT1011 Injection in Healthy Subjects

Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd.40 enrolled1 locationNCT07024160
Recruiting

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Anticoagulant TherapyCerebral Venous ThrombosisAnticoagulant Drugs+6 more
Xuanwu Hospital, Beijing1,486 enrolled1 locationNCT06947707
Recruiting

Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants

Atrial Fibrillation (AF)Ischemic StrokeOral Anticoagulation+2 more
University of L'Aquila200 enrolled47 locationsNCT06823466
Recruiting
Phase 4

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

Atrial FibrillationVenous ThromboembolismAnticoagulation
Nantes University Hospital2,100 enrolled1 locationNCT04539301
Recruiting
Phase 4

Safety of Dental Extraction on New Oral Anticoagulants (NOACs) withouT Stopping Therapy (DENTST study)

AnticoagulationDental extractions
Dr Jennifer Curnow400 enrolled1 locationACTRN12615001009505
Recruiting

Predilution online hemodiafiltration with Citrasate - is it a possible option for heparin free procedure?

anticoagulation during renal replacement therapy
Pavlina Richtrova, M.D., Ph.D.10 enrolled1 locationACTRN12613001117707
Recruiting
Phase 2

Efficacy of Oral Vitamin K to reverse chronic Warfarin Anticoagulation at 24 hours: A Phase 2 pharmacological Modelling Study.

Anticoagulation
Dr Noel Chan30 enrolled1 locationACTRN12612000665831
Recruiting

Coherex WaveCrest Left Atrial Appendage Occlusion Study A multi-center study to evaluate the safety and efficacy of the Coherex WaveCrest Left Atrial Appendage Occlusion System

Non-valvular atrial fibrillation in anticoagulation indicated and contraindicated patient and the effect of implantation of a left atrial appendage closure system.
Coherex Medical Inc.200 enrolled4 locationsACTRN12610000921088
Recruiting
Phase 3

Self Management of Anticoagulation Research Trial

Oral Anticoagulation
Royal Prince Alfred Hospital Cardiothoracic Department300 enrolled1 locationACTRN12606000019505